Literature DB >> 12878546

Antimicrobial susceptibility and macrolide resistance inducibility of Streptococcus pneumoniae carrying erm(A), erm(B), or mef(A).

George A Syrogiannopoulos1, Ioanna N Grivea, Lois M Ednie, Bülent Bozdogan, George D Katopodis, Nicholas G Beratis, Todd A Davies, Peter C Appelbaum.   

Abstract

Erythromycin-resistant Streptococcus pneumoniae isolates from young carriers were tested for their antimicrobial susceptibility; additionally, inducibility of macrolide and clindamycin resistance was investigated in pneumococci carrying erm(A), erm(B), or mef(A). Of 125 strains tested, 101 (81%) were multidrug resistant. Different levels of induction were observed with erythromycin, miocamycin, and clindamycin in erm(B) strains; however, in erm(A) strains only erythromycin was an inducer. Induction did not affect macrolide MICs in mef(A) strains.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12878546      PMCID： PMC166089          DOI： 10.1128/AAC.47.8.2699-2702.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies.

Authors:  T A Davies; L M Kelly; M R Jacobs; P C Appelbaum
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Statement 1996 CA-SFM Zone sizes and MIC breakpoints for non-fastidious organisms.

Authors: 
Journal:  Clin Microbiol Infect       Date:  1996-02       Impact factor: 8.067

3.  Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.

Authors:  Annie Canu; Brigitte Malbruny; Maëlle Coquemont; Todd A Davies; Peter C Appelbaum; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates.

Authors:  P Oster; A Zanchi; S Cresti; M Lattanzi; F Montagnani; C Cellesi; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

Review 5.  Erythromycin resistance by ribosome modification.

Authors:  B Weisblum
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

6.  Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates.

Authors:  K P Klugman; T Capper; C A Widdowson; H J Koornhof; W Moser
Journal:  J Antimicrob Chemother       Date:  1998-12       Impact factor: 5.790

7.  Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece.

Authors:  G A Syrogiannopoulos; I N Grivea; A Tait-Kamradt; G D Katopodis; N G Beratis; J Sutcliffe; P C Appelbaum; T A Davies
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

8.  A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin.

Authors:  A Rosato; H Vicarini; A Bonnefoy; J F Chantot; R Leclercq
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

9.  In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae.

Authors:  G A Pankuch; S A Jueneman; T A Davies; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

10.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191
View more
  10 in total

1.  In vitro antibacterial activity of modithromycin, a novel 6,11-bridged bicyclolide, against respiratory pathogens, including macrolide-resistant Gram-positive cocci.

Authors:  Takafumi Sato; Kazuhiro Tateda; Soichiro Kimura; Morihiro Iwata; Yoshikazu Ishii; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

2.  Induction of efflux-mediated macrolide resistance in Streptococcus pneumoniae.

Authors:  Scott T Chancey; Xiaoliu Zhou; Dorothea Zähner; David S Stephens
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

3.  Assessment of Long-Term Macrolide Exposure on the Oropharyngeal Microbiome and Macrolide Resistance in Healthy Adults and Consequences for Onward Transmission of Resistance.

Authors:  Jocelyn M Choo; Geraint B Rogers; Lucy D Burr; Steven L Taylor; Alyson Richard; Veronika Schreiber; Stevie Lingman; Megan Martin; Lito E Papanicolas
Journal:  Antimicrob Agents Chemother       Date:  2022-03-16       Impact factor: 5.938

4.  New genetic element carrying the erythromycin resistance determinant erm(TR) in Streptococcus pneumoniae.

Authors:  Romina Camilli; Maria Del Grosso; Francesco Iannelli; Annalisa Pantosti
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

5.  Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 1. Newly generated antibacterial activities against Gram-positive bacteria with erm gene by C-7 modification.

Authors:  Yoshinari Wakiyama; Ko Kumura; Eijiro Umemura; Kazutaka Ueda; Satomi Masaki; Megumi Kumura; Hideki Fushimi; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2015-12-16       Impact factor: 2.649

6.  Composite mobile genetic elements disseminating macrolide resistance in Streptococcus pneumoniae.

Authors:  Scott T Chancey; Sonia Agrawal; Max R Schroeder; Monica M Farley; Hervé Tettelin; David S Stephens
Journal:  Front Microbiol       Date:  2015-02-09       Impact factor: 5.640

7.  Genomic Epidemiology of Streptococcus suis Sequence Type 7 Sporadic Infections in the Guangxi Zhuang Autonomous Region of China.

Authors:  Mingliu Wang; Pengcheng Du; Jianping Wang; Ruiting Lan; Jun Huang; Ming Luo; Yan Jiang; Jun Zeng; Yi Quan; Zhaohui Shi; Han Zheng
Journal:  Pathogens       Date:  2019-10-12

8.  Effect of Single-dose Azithromycin on Pneumococcal Carriage and Resistance: A Randomized Controlled Trial.

Authors:  Boubacar Coulibaly; Dramane Kiemde; Guillaume Zonou; Ali Sié; Clarisse Dah; Mamadou Bountogo; Jessica Brogdon; Huiyu Hu; Elodie Lebas; Travis C Porco; Thuy Doan; Thomas M Lietman; Catherine E Oldenburg
Journal:  Pediatr Infect Dis J       Date:  2022-05-23       Impact factor: 3.806

9.  Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates from a Phase III community-acquired bacterial pneumonia (CABP) trial.

Authors:  S P McCurdy; A J Sheets; S K Cammarata; J E Vidal
Journal:  JAC Antimicrob Resist       Date:  2021-05-04

10.  A Case of In Situ Phage Therapy against Staphylococcus aureus in a Bone Allograft Polymicrobial Biofilm Infection: Outcomes and Phage-Antibiotic Interactions.

Authors:  Brieuc Van Nieuwenhuyse; Christine Galant; Bénédicte Brichard; Pierre-Louis Docquier; Sarah Djebara; Jean-Paul Pirnay; Dimitri Van der Linden; Maya Merabishvili; Olga Chatzis
Journal:  Viruses       Date:  2021-09-22       Impact factor: 5.048
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.